Antisense oligonucleotides (ASOs) represent a groundbreaking class of nucleotide-based therapeutics designed to modulate gene expression with high specificity. These synthetic strands of DNA or RNA are engineered to bind selectively to messenger RNA (mRNA), thereby influencing protein production and offering promising avenues for treating a wide range of genetic and acquired diseases.... https://www.coherentmarketinsights.com/market-insight/antisense-oligonucleotides-market-1879